Department of Family Medicine, Yonsei University College of Medicine, Seoul 03722, Korea.
Department of Medicine, Graduate School of Yonsei University College of Medicine, Seoul 03722, Korea.
Int J Environ Res Public Health. 2019 Aug 12;16(16):2883. doi: 10.3390/ijerph16162883.
Previous studies evaluating associations between resting heart rate (RHR) and cancer-related mortality/prognosis have yielded conflicting results. We investigated whether elevations in RHR are associated with colorectal cancer (CRC). We conducted a case-controlled study involving 1241 CRC patients and 5909 cancer-free controls from the Korean National Health and Nutrition Examination Survey. After propensity score (PS) matching, 1207 CRC patients and 1207 matched controls were analyzed. Associations between RHR and CRC, colon, and rectal cancer were analyzed in appropriate patient subgroups using multiple and conditional logistic regression. Receiver operating characteristics analysis yielded the optimal RHR cut-point to predict CRC. RHR was significantly higher in CRC, colon, and rectal cancer patients than in controls (72.7 bpm in CRC, 72.8 bpm in colon cancer, 72.3 bpm in rectal cancer, and 68.7 bpm in controls; all < 0.001). Analysis of data prior to PS matching yielded the following odds ratios (ORs) per RHR increment for CRC, colon, and rectal cancer: 1.043 (95% confidence intervals (CIs): 1.036-1.049), 1.045 (95% CI: 1.037-1.053), and 1.040 (95% CI: 1.030-1.051), respectively, in unadjusted models, and 1.043 (95% CI: 1.034-1.051), 1.046 (95% CI: 1.037-1.055), and 1.040 (95% CI: 1.027-1.052), respectively, in multivariable adjusted models. Patients with CRC, colon, and rectal cancer have a significantly higher RHR compared to cancer-free controls.
先前评估静息心率 (RHR) 与癌症相关死亡率/预后之间关系的研究得出了相互矛盾的结果。我们研究了 RHR 升高是否与结直肠癌 (CRC) 相关。我们进行了一项病例对照研究,纳入了来自韩国国家健康和营养检查调查的 1241 例 CRC 患者和 5909 例无癌症对照。在进行倾向评分 (PS) 匹配后,分析了 1207 例 CRC 患者和 1207 例匹配对照。在适当的患者亚组中,使用多元和条件逻辑回归分析 RHR 与 CRC、结肠癌和直肠癌之间的关系。接收者操作特征分析得出了预测 CRC 的最佳 RHR 切点。CRC、结肠癌和直肠癌患者的 RHR 明显高于对照组(CRC 患者为 72.7 bpm,结肠癌患者为 72.8 bpm,直肠癌患者为 72.3 bpm,对照组为 68.7 bpm;均 < 0.001)。在进行 PS 匹配之前进行数据分析,得出了 RHR 每增加时 CRC、结肠癌和直肠癌的优势比 (OR):未调整模型中分别为 1.043(95%置信区间(CI):1.036-1.049)、1.045(95% CI:1.037-1.053)和 1.040(95% CI:1.030-1.051),调整模型中分别为 1.043(95% CI:1.034-1.051)、1.046(95% CI:1.037-1.055)和 1.040(95% CI:1.027-1.052)。与无癌症对照相比,CRC、结肠癌和直肠癌患者的 RHR 明显更高。